# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001698530-24-000134
Filing Date
2024-12-02
Accepted
2024-12-02 12:00:52
Documents
4
Period of Report
2024-12-02

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | exicureproxystmt-specialmt.htm | DEF 14A | 576996
2 |  | exicureproxy_image1a.jpg | GRAPHIC | 170008
3 |  | proxycardv41125_pagex1a.jpg | GRAPHIC | 444106
4 |  | proxycardv41125_pagex2a.jpg | GRAPHIC | 198735
| Complete submission text file | 0001698530-24-000134.txt |  | 1686246

Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39011 | Film No.: 241517940
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)